Immunoassay Market Share

North American Market Forecast

The North America immunoassay market is poised to generate the highest revenue share of 41% by the end of 2037. This growth of the market in this region is poised to be encouraged by growing healthcare investment. The health spending offered by the federal government stood at 33 percent whereas the households amounted to 28 percent.  The share of private business on health spending accounted for 18 percent of total expenditure on health care. Further, state and local governments reached 15 percent, and other private organizations accounted for 7 percent. Moreover, this region is also observing high investment in cutting-edge technology. Hence, the deployment of such technologies is predicted to rise in immunoassay in this region since it is predicted to reduce the price of the treatment.

APAC Market Analysis

The Asia Pacific excluding Japan immunoassay market is also predicted to have notable growth over the coming years. Asia Pacific Excluding Japan is estimated to have the quickest-growing market for Immunoassay owing to the emergence of the COVID-19 pandemic which has further led to the production of rapid diagnostic tests (RDTs) which utilize immunoassay techniques. Moreover, this region is projected to have the presence of a huge number of key players in the field of immunoassay. As a result, this factor is also estimated to dominate the market expansion in this region.